The central drug regulator the Central Drugs Standard Control Organisation (CDSCO) has informed the World Health Organisation (WHO) about the halt in the production of Coldrif, Respifresh TR and ReLife, which it has deemed toxic. The CDSCO has also communicated to the the global
Approved by Ministry of Information & Broadcasting(GOI) Level II Self Regulatory body for News Publishers & Current Affairs.
Regd No : JMAGC/HR/00072


